Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to $73161.0.

  • Immucell's Share-based Compensation fell 566.81% to $73161.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $260953.0, marking a year-over-year decrease of 2697.49%. This contributed to the annual value of $325551.0 for FY2024, which is 1174.27% down from last year.
  • As of Q3 2025, Immucell's Share-based Compensation stood at $73161.0, which was down 566.81% from $66714.0 recorded in Q2 2025.
  • Over the past 5 years, Immucell's Share-based Compensation peaked at $100659.0 during Q4 2023, and registered a low of $23265.0 during Q2 2021.
  • Over the past 5 years, Immucell's median Share-based Compensation value was $68863.0 (recorded in 2024), while the average stood at $68266.6.
  • Per our database at Business Quant, Immucell's Share-based Compensation plummeted by 5892.04% in 2021 and then surged by 16492.59% in 2022.
  • Over the past 5 years, Immucell's Share-based Compensation (Quarter) stood at $40931.0 in 2021, then skyrocketed by 59.77% to $65395.0 in 2022, then surged by 53.92% to $100659.0 in 2023, then crashed by 31.59% to $68863.0 in 2024, then rose by 6.24% to $73161.0 in 2025.
  • Its Share-based Compensation stands at $73161.0 for Q3 2025, versus $66714.0 for Q2 2025 and $52215.0 for Q1 2025.